Evans linked the upregulation of genes such as RPP38-DT to immunosuppressive therapy by gene enrichment analysis, suggesting that their interaction may be involved in the treatment of non-small-cell lung cancer [37]. Here, RPP38 is linked to non-small cell lung carcinoma.